Basic Information
| LncRNA/CircRNA Name | ASB16-AS1 |
| Synonyms | NA |
| Region | GRCh38_17:44175973-44186717 |
| Ensemble | ENSG00000267080 |
| Refseq | NR_049729 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | cervical cancer |
| ICD-0-3 | C53 |
| Methods | qRT-PCR, Western blot |
| Sample | CC tissues,cell lines |
| Expression Pattern | up-regulated |
| Function Description | ASB16-AS1 promotes cell proliferation, migration, invasion via binding miR-1305 with Wnt2, and enhancing the Wnt/?-catenin pathway. |
| Pubmed ID | 32058219 |
| Year | 2020 |
| Title | Long non-coding RNA ASB16-AS1 enhances cell proliferation, migration and invasion via functioning as a ceRNA through miR-1305/Wnt/?-catenin axis in cervical cancer |
External Links
| Links for ASB16-AS1 | GenBank HGNC NONCODE |
| Links for cervical cancer | OMIM COSMIC |